Epigral Limited has announced that CRISIL Ratings has reaffirmed its ratings on the company's bank facilities. The total bank loan facilities rated amount to ₹1050 Crore. The long-term rating has been reaffirmed as CRISIL AA with a Stable outlook, and the short-term rating has been reaffirmed as CRISIL A1+. The rating rationale was published by CRISIL Ratings on their website on June 02, 2026. This announcement was made on June 03, 2026, in accordance with SEBI Listing Regulations.
